Kane Biotech Inc. (KNBIF)
Kane Biotech Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Winnipeg, MB, CA. The stock last traded at $0.02, up 2.22% on the session, giving a market capitalisation of $3.8M. On trailing twelve-month figures it carries a trailing P/E of -1.98, a net margin of -3785.9%. Its beta of 0.31 implies it has historically moved less than the broad market.
Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.
Kane Biotech Inc. is most often compared with the following Healthcare names: